Ferndale Laboratories
United States 129 employees Updated 9 July 2026
Ferndale Laboratories is a finished-dose manufacturer based in United States. It appears in 19 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, EMA and MPA (SE). Its GMP standing is certified by US FDA and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 27 February 2026 as VAI.
2
registered plants
1 with an FDA FEI number
19
filings
across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 27 February 2026 VAI US FDA
- 4 March 2022 VAI US FDA
- 3 February 2017 VAI US FDA
- 24 April 2015 VAI US FDA
- 14 January 2014 VAI US FDA
- 13 December 2011 VAI US FDA
- 7 January 2011 NAI US FDA
- 18 August 2010 OAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| FERNDALE, United States | Not on file |
| Ferndale, United States | 1811212 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 16 | 1 |
| EMA | 2 | None |
| MPA (SE) | 1 | None |
| MHRA (UK) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Ferndale Laboratories comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 27 February 2026.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates